These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23055017)

  • 1. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
    Aiad HA; Bashandy MA; Abdou AG; Zahran AA
    Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of AgNOR staining in thyroid cytology.
    Shechtman L; Koren R; Horowitz A; Shechtman I; Halpern M; Gal R
    Anal Quant Cytol Histol; 1998 Jun; 20(3):187-91. PubMed ID: 9642445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases.
    Ciobanu D; Căruntu ID; Vulpoi C; Florea N; Giuşcă SE
    Rom J Morphol Embryol; 2006; 47(4):323-30. PubMed ID: 17392977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ki-67 as a proliferative marker in lesions of thyroid.
    Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
    Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgNOR quantification in the diagnosis of follicular pattern thyroid lesions.
    Słowińska-Klencka D; Klencki M; Popowicz B; Lewiński A
    Anal Quant Cytol Histol; 2003 Dec; 25(6):347-52. PubMed ID: 14714301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
    Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
    Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
    Lewy-Trenda I; Bieńkiewicz M
    Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative diagnosis of thyroid cancer by karyometry of thyrocytes].
    Kirillov VA; Iushchenko IuP
    Klin Lab Diagn; 1996; (2):14-6. PubMed ID: 8680758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions.
    Mehrotra A; Goel MM; Singh K
    Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
    Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
    Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma.
    Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A
    Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.
    Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A
    Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometric analysis of the degree of thyrocyte aggregation in the preoperative diagnosis of thyroid cancer].
    Kirillov VA; Iushchenko IuP
    Klin Lab Diagn; 1996; (4):13-6. PubMed ID: 8963549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression.
    Slowińska-Klencka D; Klencki M; Popowicz B; Sporny S; Lewiński A
    Histol Histopathol; 2004 Jul; 19(3):785-92. PubMed ID: 15168341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic nucleolar organizing region associated protein synthesis for cytologic discrimination of follicular thyroid lesions.
    Oktay M; Eroz R; Oktay NA; Erdem H; Başar F; Akyol L; Cucer N; Bahadir A
    Biotech Histochem; 2015 Apr; 90(3):179-83. PubMed ID: 25420891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of qualitative and quantitative variables in thyroid lesions.
    Rout P; Shariff S
    Cytopathology; 1999 Jun; 10(3):171-9. PubMed ID: 10390065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
    Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
    Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.